Harnessing the regenerative power of amniotic fluid and amniotic membrane

Eliksa Therapeutics was founded in 2021 to deliver on the mission of harnessing the regenerative properties of amniotic fluid and amniotic membrane to heal human disease.

Sector: Healthcare

Sub Sector: Biologics, Cell & Gene Therapy

Industry: Biotechnology

Status: Active

County: Bucks